Table 2 Number of positive samples according to the technical procedure: nasopharyngeal RT-PCR, saliva RT-LAMP or RT-PCR and nasopharyngeal antigen test.
From: Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care
Positive/total (%) | Presence of symptoms on day of testing | ||
|---|---|---|---|
Symptoms | No symptoms | ||
Nasopharyngeal RT-PCR | 117/1718 (7%) | 78/691 (11%) | 39/1027 (4%) |
Saliva RT-LAMP | 88/1718 (5%) | 47/691 (7%) | 41/1027 (4%) |
Saliva RT-PCR | 153/1640 (9%) | 93/662 (14%) | 60/978 (6%) |
Nasopharyngeal antigen test | 110/1474 (7%) | 78/652 (12%) | 32/822 (4%) |
